Open Access
CC BY-NC-ND 4.0 · Endoscopy 2017; 05(05): E324-E330
DOI: 10.1055/s-0043-104860
Original article
Eigentümer und Copyright ©Georg Thieme Verlag KG 2017

Use of over-the-scope clips (OTSC) for hemostasis in gastrointestinal bleeding in patients under antithrombotic therapy

Regina Lamberts
1   HELIOS Park-Klinikum Leipzig, Klinik für Innere Medizin II, Leipzig, Germany
,
Anna Koch
1   HELIOS Park-Klinikum Leipzig, Klinik für Innere Medizin II, Leipzig, Germany
,
Christian Binner
2   Herzzentrum Leipzig, Klinik für Herzchirurgie, Leipzig, Germany
,
Marcus Zachäus
1   HELIOS Park-Klinikum Leipzig, Klinik für Innere Medizin II, Leipzig, Germany
,
Ingrid Knigge
1   HELIOS Park-Klinikum Leipzig, Klinik für Innere Medizin II, Leipzig, Germany
,
Mark Bernhardt
1   HELIOS Park-Klinikum Leipzig, Klinik für Innere Medizin II, Leipzig, Germany
,
Ulrich Halm
1   HELIOS Park-Klinikum Leipzig, Klinik für Innere Medizin II, Leipzig, Germany
› Author Affiliations
Further Information

Publication History

submitted 02 November 2016

accepted after revision 02 February 2017

Publication Date:
05 May 2017 (online)

Preview

Abstract

Background and study aims In patients taking different regimens of antithrombotic and/or anticoagulant therapy, endoscopic management of gastrointestinal bleeding represents a major challenge due to failing endogenous hemostasis. In this retrospective study we report on success rates with the over-the-scope clip (OTSC) system in upper and lower gastrointestinal bleeding in this high-risk patient population.

Patients and methods Between February 2011 and June 2014, 75 patients were treated with an OTSC for active gastrointestinal bleeding. Success rates with the first endoscopic therapy, rebleeding episodes, their management and the influence of antithrombotic or anticoagulant therapy were analyzed retrospectively.

Results Application of the OTSC resulted in immediate hemostasis (primary success rate) in all 75 patients. However, in 34.7 % a rebleeding episode was noted that could be treated by further endoscopic interventions. Only 3 patients had to be sent to the operating room because of failure of endoscopic therapy. In the rebleeding group the use of antiplatelet therapies was higher (73.1 % vs. 48.9 %).

Conclusions Application of the OTSC in GI bleeding results in a high rate of primary hemostasis. Rebleeding occurs in up to 35 % of patients receiving antithrombotic/anticoagulant therapy but can be managed successfully with further endoscopic treatments. Patients in the rebleeding group were more frequently treated with antiplatelet agents. Radiological or surgical therapy was reserved for a small subgroup not successfully managed by repeated endoscopic therapies. OTSC application is the treatment of choice in high-risk patients when conventional clips used as first-line treatment fail.